![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 49, 38402-38409, December 8, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
§,
, and
From the ¶ Department of Pathology, Washington University
School of Medicine, St. Louis, Missouri 63110 and N-Linked oligosaccharides terminating
with the sequence SO4-4-GalNAc
Zentrum
fuer Molekulare Neurobiologie, Universitaet Hamburg,
Martinistrasse 52, D-20246 Hamburg, Germany
1,4GlcNAc
1,2Man
are
present on the pituitary hormones lutropin (LH), thyrotropin, and
pro-opiomelanocortin. The sulfated structures on LH are essential for
expression of its biologic function in vivo. We have cloned
the N-acetylgalactosamine-4-sulfotransferase (GalNAc-4-ST1,
GenBankTM accession number AF300612), which mediates
sulfate addition to the N-linked oligosaccharides on LH and
other pituitary glycoproteins with terminal (
1,4-linked GalNAc based
on its homology to HNK-1 sulfotransferase (HNK-1 ST). GalNAc-4-ST1
displays 23% identity to HNK-1 ST and 28% to chondroitin
4-sulfotransferase 1 (C4ST-1) and 26% to chondroitin
4-sulfotransferase 2 (C4ST-2). The cDNA predicts a type II
transmembrane protein of 424 amino acids with four potential
N-linked glycosylation sites and a single membrane-spanning domain. GalNAc-4-ST1 has putative 5'-phosphosulfonate and 3'-phosphate binding sites. Three more carboxyl-terminal regions of unknown function
also show a high degree of identity with HNK-1 ST, C4ST-1, and C4ST-2.
The membrane-bound form of GalNAc-4-ST1 transfers sulfate to
GalNAc
1,4GlcNAc
-R but not to chondroitin, whereas truncated
forms of GalNAc-4-ST1 that are released into the medium transfer sulfate to both GalNAc
1,4GlcNAc
-R and chondroitin. The first 118 amino acids of GalNAc-4-ST1 appear to contribute to both
its activity and specificity for terminal
1,4-linked GalNAc.
GalNAc-4-ST1 also efficiently transfers sulfate to N-linked oligosaccharides on native LH and other glycoproteins terminating with
1,4-linked GalNAc. A single transcript of 2.4 kilobases is most
highly expressed in the pituitary and other regions of the central
nervous system. The GalNAc-4-ST1 gene is located on human chromosome
19q13.1.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF300612.
§ Contributed equally to this work.
To whom correspondence should be addressed: Washington
University School of Medicine, Dept. of Pathology, 660 S. Euclid Ave., St. Louis, MO 63110. Tel.: 314-362-8730; Fax: 314-362-8888; E-mail: baenziger@pathology.wustl.edu.
This article has been cited by other articles:
![]() |
A. V. Nairn, W. S. York, K. Harris, E. M. Hall, J. M. Pierce, and K. W. Moremen Regulation of Glycan Structures in Animal Tissues: TRANSCRIPT PROFILING OF GLYCAN-RELATED GENES J. Biol. Chem., June 20, 2008; 283(25): 17298 - 17313. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fiete, Y. Mi, E. L. Oats, M. C. Beranek, and J. U. Baenziger N-Linked Oligosaccharides on the Low Density Lipoprotein Receptor Homolog SorLA/LR11 Are Modified with Terminal GalNAc-4-SO4 in Kidney and Brain J. Biol. Chem., January 19, 2007; 282(3): 1873 - 1881. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Boregowda, Y. Mi, H. Bu, and J. U. Baenziger Differential expression and enzymatic properties of GalNAc-4-sulfotransferase-1 and GalNAc-4-sulfotransferase-2 Glycobiology, December 1, 2005; 15(12): 1349 - 1358. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Raju and M. C. Dalakas Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes Brain, August 1, 2005; 128(8): 1887 - 1896. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. S. Kawar, S. M. Haslam, H. R. Morris, A. Dell, and R. D. Cummings Novel Poly-GalNAc{beta}1-4GlcNAc (LacdiNAc) and Fucosylated Poly-LacdiNAc N-Glycans from Mammalian Cells Expressing {beta}1,4-N-Acetylgalactosaminyltransferase and {alpha}1,3-Fucosyltransferase J. Biol. Chem., April 1, 2005; 280(13): 12810 - 12819. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Barret, L. Forestier, J.-P. Deslys, R. Julien, and P. F. Gallet Glycosylation-related Gene Expression in Prion Diseases: PrPSc ACCUMULATION IN SCRAPIE INFECTED GT1 CELLS DEPENDS ON {beta}-1,4-LINKED GalNAc-4-SO4 HYPOSULFATION J. Biol. Chem., March 18, 2005; 280(11): 10516 - 10523. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mikami, S. Mizumoto, N. Kago, H. Kitagawa, and K. Sugahara Specificities of Three Distinct Human Chondroitin/Dermatan N-Acetylgalactosamine 4-O-Sulfotransferases Demonstrated Using Partially Desulfated Dermatan Sulfate as an Acceptor: IMPLICATION OF DIFFERENTIAL ROLES IN DERMATAN SULFATE BIOSYNTHESIS J. Biol. Chem., September 19, 2003; 278(38): 36115 - 36127. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Okuda, T. Sawada, H. Nakano, K. Matsubara, Y. Matsuda, M. Fukuta, and O. Habuchi Mouse N-Acetylgalactosamine 4-Sulfotransferases-1 and -2. Molecular Cloning, Expression, Chromosomal Mapping and Detection of Their Activity with GalNAc{beta}1-4GlcNAc{beta}1-octyl J. Biochem., July 1, 2003; 134(1): 111 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. I. Park, S. M. Manzella, and J. U. Baenziger Rapid Clearance of Sialylated Glycoproteins by the Asialoglycoprotein Receptor J. Biol. Chem., February 7, 2003; 278(7): 4597 - 4602. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Woodworth, D. Fiete, and J. U. Baenziger Spatial and Temporal Regulation of Tenascin-R Glycosylation in the Cerebellum J. Biol. Chem., December 20, 2002; 277(52): 50941 - 50947. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Strott Sulfonation and Molecular Action Endocr. Rev., October 1, 2002; 23(5): 703 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-G. Kang, M. R. Evers, G. Xia, J. U. Baenziger, and M. Schachner Molecular Cloning and Characterization of Chondroitin-4-O-sulfotransferase-3. A NOVEL MEMBER OF THE HNK-1 FAMILY OF SULFOTRANSFERASES J. Biol. Chem., September 13, 2002; 277(38): 34766 - 34772. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. S. Kawar, I. Van Die, and R. D. Cummings Molecular Cloning and Enzymatic Characterization of a UDP-GalNAc:GlcNAcbeta -R beta 1,4-N-Acetylgalactosaminyltransferase from Caenorhabditis elegans J. Biol. Chem., September 13, 2002; 277(38): 34924 - 34932. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fukuda, N. Hiraoka, T. O. Akama, and M. N. Fukuda Carbohydrate-modifying Sulfotransferases: Structure, Function, and Pathophysiology J. Biol. Chem., December 14, 2001; 276(51): 47747 - 47750. [Full Text] [PDF] |
||||
![]() |
N. Hiraoka, A. Misra, F. Belot, O. Hindsgaul, and M. Fukuda Molecular cloning and expression of two distinct human N-acetylgalactosamine 4-O-sulfotransferases that transfer sulfate to GalNAc{beta}1{->}4GlcNAc{beta}1{->}R in both N- and O-glycans Glycobiology, June 1, 2001; 11(6): 495 - 504. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-G. Kang, M. R. Evers, G. Xia, J. U. Baenziger, and M. Schachner Molecular Cloning and Expression of an N-Acetylgalactosamine-4-O-sulfotransferase That Transfers Sulfate to Terminal and Non-terminal beta 1,4-Linked N-Acetylgalactosamine J. Biol. Chem., March 30, 2001; 276(14): 10861 - 10869. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Evers, G. Xia, H.-G. Kang, M. Schachner, and J. U. Baenziger Molecular Cloning and Characterization of a Dermatan-specific N-Acetylgalactosamine 4-O-Sulfotransferase J. Biol. Chem., September 21, 2001; 276(39): 36344 - 36353. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |